---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "KKSdcnFAtA2Yn+unlvjt0zDajRkkhM2NHqQpkxNlVyaPo/E5TIfqfJfhlsmjd8Lw1hUMUsYGml4wQwgqBZkZ81uVj2syiu6/c79WSxyRZmGBI+FSI/g2CT8Xnfs/5F4j28fpwHTPuT921JCPYSW+kif9CTIldY5406BiY7wY+MsRYsmnQowrup+xA8cXoDPG7Jbo7lPqxWGTaltn2zbgo16Uj0yoko+23o1oFZmsyY0k5n2zNfDSCzWgkdXQwAStB+CQ3BMhfPBHKrZ2vCSbUWPjsNe9nYo5q80yS4/q5tRcSlwNOzq97cW6fjwEfdLUnwvmCC2lxi2zc2r09CzecagAHXeTAsO3+cEevjOYg0w=;ciBYPwLKsR5E9icPyP4d8g=="
---

